These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 31655499)
1. Assessment of treatment efficacy of diphenylcyclopropenone (DPCP) for alopecia areata. Kutlubay Z; Sevim A; Aydın Ö; Vehid S; Serdaroğlu S Turk J Med Sci; 2020 Dec; 50(8):1817-1824. PubMed ID: 31655499 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series. Durdu M; Özcan D; Baba M; Seçkin D J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series. Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933 [TBL] [Abstract][Full Text] [Related]
4. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients. Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948 [TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin. Ibrahim SA; Esawy AM; Abdelshafy AS Dermatol Ther; 2019 Sep; 32(5):e13010. PubMed ID: 31237076 [TBL] [Abstract][Full Text] [Related]
6. Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience. El Khoury J; Abd-el-Baki J; Succariah F; Abbas O; Kibbi AG; Kurban M Int J Dermatol; 2013 Dec; 52(12):1551-6. PubMed ID: 24134785 [TBL] [Abstract][Full Text] [Related]
7. Serum level of IL-4 predicts response to topical immunotherapy with diphenylcyclopropenone in alopecia areata. Gong Y; Zhao Y; Zhang X; Qi S; Li S; Ye Y; Yang J; Caulloo S; McElwee KJ; Zhang X Exp Dermatol; 2020 Mar; 29(3):231-238. PubMed ID: 30047620 [TBL] [Abstract][Full Text] [Related]
8. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata. Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402 [TBL] [Abstract][Full Text] [Related]
9. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA). Galadari I; Rubaie S; Alkaabi J; Galadari H Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526 [TBL] [Abstract][Full Text] [Related]
10. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata. Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987 [TBL] [Abstract][Full Text] [Related]
11. A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata. Al Bazzal A; Hatami P; Abedini R; Etesami I; Ayanian Z; Ghandi N Int Immunopharmacol; 2021 Dec; 101(Pt B):108186. PubMed ID: 34710658 [TBL] [Abstract][Full Text] [Related]
12. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population. Aghaei S BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata. Luk NM; Chiu LS; Lee KC; Chau CT; Lee VW; Chang M; Lam YK; Lee HC J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e400-5. PubMed ID: 23057682 [TBL] [Abstract][Full Text] [Related]
14. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis. Lee S; Kim BJ; Lee YB; Lee WS JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292 [TBL] [Abstract][Full Text] [Related]
15. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480 [TBL] [Abstract][Full Text] [Related]
16. Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases. Choe SJ; Lee S; Pi LQ; Keum DI; Lee CH; Kim BJ; Lee WS J Am Acad Dermatol; 2018 Mar; 78(3):515-521.e4. PubMed ID: 29108907 [TBL] [Abstract][Full Text] [Related]
17. Diphenylcyclopropenone in patients with alopecia areata. A critically appraised topic. Kuin RA; Spuls PI; Limpens J; van Zuuren EJ Br J Dermatol; 2015 Oct; 173(4):896-909. PubMed ID: 26511831 [TBL] [Abstract][Full Text] [Related]
18. Is the severity of initial sensitization to diphenylcyclopropenone in alopecia areata patients predictive of the final clinical response? Ghandi N; Seifi G; Nasimi M; Abedini R; Mirabedian S; Etesami I; Ehsani A Dermatol Ther; 2021 Nov; 34(6):e15118. PubMed ID: 34464020 [TBL] [Abstract][Full Text] [Related]
19. Diphenylcyclopropenone plays an effective therapeutic role by up-regulating the TSLP/OX40L/IL-13 pathway in severe alopecia areata. Gong Y; Luo L; Li L; He X; Lu W; Sha X; Mao Y Exp Dermatol; 2021 Feb; 30(2):278-283. PubMed ID: 33325128 [TBL] [Abstract][Full Text] [Related]
20. Predictive model for immunotherapy of alopecia areata with diphencyprone. Wiseman MC; Shapiro J; MacDonald N; Lui H Arch Dermatol; 2001 Aug; 137(8):1063-8. PubMed ID: 11493099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]